Real-world effectiveness of Yindan Jiedu granules-based treatment on patients infected with the SARS-CoV-2 Omicron variants BA.2 combined with high-risk factors: A cohort study

Background: Our previous studies have shown that Yindan Jiedu granules (YDJDG) can effectively treat coronavirus disease 2019 (COVID-19); however, the high infectivity and the immune escape potential of the Omicron variant BA.2 make it more difficult to control, and patients with high-risk factors p...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Ying, Liu, Yao, Liu, Long, Jiang, Yuyong, Hou, Yixin, Zhou, Yang, Song, Rui, Chen, Xiaoyou, Wang, Xianbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426238/
https://www.ncbi.nlm.nih.gov/pubmed/36052136
http://dx.doi.org/10.3389/fphar.2022.978979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426238/
https://www.ncbi.nlm.nih.gov/pubmed/36052136
http://dx.doi.org/10.3389/fphar.2022.978979

Ejemplares similares